MedPath

Outcomes of Critically Ill Patients Undergoing RRT- a Registry Based Study.

Completed
Conditions
Renal Replacement Therapies
Outcome Assessment
Registration Number
NCT06897254
Lead Sponsor
Tribhuvan University Teaching Hospital, Institute Of Medicine.
Brief Summary

Rationale: Acute kidney injury (AKI) requiring renal replacement therapy (RRT) is a frequently occurring entity among critically ill patients. This study aims to determine the outcomes of patients undergoing renal replacement therapy in the ICU.

Study Objective: To find the outcomes of patients undergoing RRT in the ICU in terms of mortality and length of ICU stay.

Design: A registry based, retrospective, descriptive study. Sample size: Convenience sampling of all the patients who require RRT during the ICU stay.

Duration: Retrospective data from three years January 1, 2020 to December 30, 2023.

Place: Intensive care units (ICUs) of the Department of Critical Care Medicine, Tribhuvan University Teaching Hospital (TUTH).

Interventions: Not applicable Expected results: The study will help determine the outcomes of the critically ill patients undergoing RRT in a low middle income country ICU.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
516
Inclusion Criteria
  • Age>18 years
  • Admission to the ICU
  • All patients undergoing RRT during ICU stay
Exclusion Criteria
  • None

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ICU mortalityA the end of 3 years
Secondary Outcome Measures
NameTimeMethod
Treatment limitationsAt the end of 3 years

Patients who receiving treatment limitation orders (Leave against medical advice, do not resuscitate/do not intubate, withdrawal of treatment orders)

Trial Locations

Locations (1)

Tribhuvan University Teaching Hospital

🇳🇵

Maharajganj, Bagmati, Nepal

Tribhuvan University Teaching Hospital
🇳🇵Maharajganj, Bagmati, Nepal

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.